Sometimes all it takes is a small reminder to get people to take better care of their health.

At least researchers found that using a computerized reminder system increased colorectal cancer screening rates by an average of 9 percent at community-based primary care doctors' offices

A government panel of experts has released its final report on the possible human effects of bisphenol A, or BPA, a chemical added to plastics to make it stronger.

The National Toxicology Program, part of the National Institutes of Health, notes "some concern" for effects on the brain, prostate gland, and on behavior in fetuses, infants, and children

Scientists say they may be able to develop treatments for children with Down's syndrome after the discovery of earliest developmental changes that lead to the illness.

A team of researchers from Barts and the Royal London have found the earliest developmental changes in embryonic stem cells caused by an extra copy of human chromosome 21 that sets off a chain of genetic changes in the developing embryo which results in the condition

A drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis but it may increase the chances of death from cancer or stroke, the U.S. Food and Drug Administration (FDA) noted Thursday.

Pfizer's Fablyn is taken once daily as a tablet to prevent fractures in postmenopausal women with osteoporosis. The drug lasofoxifene tartrate or Fablyn was rejected by the FDA in September 2005 as a medicine to prevent osteoporosis

Four rheumatoid arthritis drugs have received stronger warnings from the U.S. Food and Drug Administration (FDA) after the drugs have been linked to deaths in 45 patients.

The FDA has received 240 reports of people taking the drugs Cimzia, Enbrel, Humira, and Remicade, which are called TNF blockers. All of then developed histoplasmosis, a fungal infection that starts as a respiratory infection and can spread throughout the body